JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 4, 2005; DOI: 10.1124/jpet.105.090621


0022-3565/05/3152-771-776$20.00
JPET 315:771-776, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.090621v1
315/2/771    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solt, K.
Right arrow Articles by Raines, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solt, K.
Right arrow Articles by Raines, D. E.

NEUROPHARMACOLOGY

General Anesthetic-Induced Channel Gating Enhancement of 5-Hydroxytryptamine Type 3 Receptors Depends on Receptor Subunit Composition

Ken Solt, Renna J. Stevens, Paul A. Davies, and Douglas E. Raines

Department of Anesthesia and Critical Care, Massachusetts General Hospital, and Department of Anesthesia, Harvard Medical School, Boston, Massachusetts (K.S., P.A.D., D.E.R.); and Neuroscience Program, University of California at San Diego, San Diego, California (R.J.S.)

5-Hydroxytryptamine (serotonin) (5-HT) type 3 (5-HT3) receptors are members of an anesthetic-sensitive superfamily of Cys-loop ligand-gated ion channels that can be formed as homomeric 5-HT3A or heteromeric 5-HT3AB receptors. When the efficacious agonist 5-HT is used, the inhaled anesthetics halothane and chloroform (at clinically relevant concentrations) significantly reduce the agonist EC50 for 5-HT3A receptors but not for 5-HT3AB receptors. In the present study, we used dopamine (DA), a highly inefficacious agonist for 5-HT3 receptors, to determine whether the difference in sensitivity between 5-HT3A and 5-HT3AB receptors to the potentiating effects of halothane and chloroform is due to differential modulation of agonist affinity, channel gating, or both. Using the two-electrode voltage-clamp technique with 5-HT3A and 5-HT3AB receptors expressed in Xenopus oocytes, we found that chloroform and halothane enhanced currents evoked by receptor-saturating concentrations of DA for both receptor subtypes in a concentration-dependent manner but that the magnitude of enhancement was substantially greater for 5-HT3A receptors than for 5-HT3AB receptors. Isoflurane induced only a small enhancement of currents evoked by receptor-saturating concentrations of DA for 5-HT3A receptors and no enhancement for 5-HT3AB receptors. For both receptor subtypes, none of the three test anesthetics significantly altered the agonist EC50 for DA, implying that these anesthetics do not affect agonist binding affinity. Our results show that chloroform, halothane, and (to a much lesser degree) isoflurane enhance channel gating for 5-HT3A receptors and that the incorporation of 5-HT3B subunits to produce heteromeric 5-HT3AB receptors markedly attenuates the ability of these anesthetics to enhance channel gating.


Received June 6, 2005; accepted August 3, 2005.

Address correspondence to: Dr. Ken Solt, Department of Anesthesia and Critical Care, Massachusetts General Hospital, 55 Fruit St., Edwards 505, Boston, MA 02114. E-mail: ksolt{at}partners.org




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters
Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor
J. Biol. Chem., July 11, 2008; 283(28): 19301 - 19313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-Q. Hu and R. W. Peoples
The 5-HT3B Subunit Confers Spontaneous Channel Opening and Altered Ligand Properties of the 5-HT3 Receptor
J. Biol. Chem., March 14, 2008; 283(11): 6826 - 6831.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Solt, D. Ruesch, S. A. Forman, P. A. Davies, and D. E. Raines
Differential Effects of Serotonin and Dopamine on Human 5-HT3A Receptor Kinetics: Interpretation within an Allosteric Kinetic Model
J. Neurosci., November 28, 2007; 27(48): 13151 - 13160.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Rusch, B. Musset, H. Wulf, A. Schuster, and D. E. Raines
Subunit-Dependent Modulation of the 5-Hydroxytryptamine Type 3 Receptor Open-Close Equilibrium by n-Alcohols
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1069 - 1074.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.